Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: South Korea Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20051
20063
20081
20094
20103
20114
20122
20132
20143
20153
20166
20178
20188
20192
20209
20217
20224
20234
20245
202512
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Active, not recruiting20
Recruiting17
Terminated13
Unknown status4
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center8
AbbVie7
Amgen7
AstraZeneca7
Hoffmann-La Roche6
Merck Sharp & Dohme LLC6
Eli Lilly and Company5
GlaxoSmithKline5
National Cancer Center, Korea5
Bristol-Myers Squibb3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma98
Carcinoma, Non-Small-Cell Lung10
Lung Neoplasms8
Breast Neoplasms6
Ovarian Neoplasms6
Neoplasm Metastasis5
Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Stomach Neoplasms5
Triple Negative Breast Neoplasms5

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.